Vital Signs Market

`

Sort By

1-10 of 308

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  1. Vital Signs The Analyst's Perspective - July 2016 Issue
    30
    Aug 2016
    This Vital Signs issue discusses the clinical diagnostics laboratory tests payment system, approval of a Zika test kit, the impact on innovation of mergers in the pharma/biotech industry, and national healthcare expenditure projections through 2025.
    USD 600
    Read More
  2. Vital Signs The Analyst's Perspective - June 2016 Issue
    02
    Aug 2016
    This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.
    USD 450
    Read More
  3. Vital Signs The Analyst's Perspective - May 2016 Issue
    30
    Jun 2016
    This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.
    USD 450
    Read More
  4. Vital Signs The Analyst's Perspective - April 2016 Issue
    24
    May 2016
    This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.
    USD 450
    Read More
  5. Vital Signs - Emerging Trends and Opportunities in Life Sciences, February 2016
    04
    Apr 2016

    Vital Signs - Emerging Trends and Opportunities in Life Sciences, February 2016

    Exciting Developments in Generic Drug Pricing, CRISPR Technology, GenomeAsia 100K and Large-scale Next-generation Sequencing Projects, and Medicare Outcomes

    Region : Global

    This Vital Signs issues discusses generic drug pricing, CRISPR technology, GenomeAsia 100K and large-scale next-generation sequencing projects, and Medicare outcomes target.
    USD 450
    Read More
  6. Vital Signs - Impact on Medical Imaging of Deep Learning and Internet of Things (IoT), HIMSS 2016
    24
    Mar 2016

    Vital Signs - Impact on Medical Imaging of Deep Learning and Internet of Things (IoT), HIMSS 2016

    Competitive Strategies and Time to Market are Key to Maximizing on Emerging Growth Opportunities

    Region : North America

    As every year, Frost & Sullivan attended the annual HIMSS meeting, where we explore new trending themes unveiling new opportunities in medical imaging. The two themes pertaining to medical imaging that we explored at the 2016 edition are: I. The Internet of Medical Imaging Things: Assessing the Strategy of the Big Three. II. Deep Learning in Medica...
    USD 750
    Read More
  7. Vital Signs - Drug Development Focus on Genetically Modified Swine
    18
    Mar 2016

    Vital Signs - Drug Development Focus on Genetically Modified Swine

    Modified Swine Hold out Promise of Improving Pre-Clinical Efficacy, Lowering Multi-billion Dollar Drug and Device Development Costs

    Region : North America

    The US pharmaceutical industry spends approximately $100 billion annually to develop new pharmaceutical drugs and medical devices. Today, a new drug takes approximately 15 years and over $1 billion to bring to market. Product development costs could be greatly reduced by using animal models that more closely resemble humans in their disease states ...
    USD 450
    Read More
  8. Vital Signs - Stem Cell Therapy in Ischemic Stroke Recovery
    18
    Mar 2016

    Vital Signs - Stem Cell Therapy in Ischemic Stroke Recovery

    Additional Clinical Trials Critical to Building on Early Promise

    Region : North America

    As indicated by the World Health Organization, stroke is the second-leading cause of death for people over the age of 60 and is the fifth-leading cause of death for those between the ages of 15 and 59. The incidence of stroke is expected to increase by 25% over the next 20 years. Over 40% of ischemic stroke victims have permanent symptoms and only ...
    USD 450
    Read More
  9. Vital Signs - Impact of Strategic Acquisitions on Life Sciences Market, 2016
    12
    Feb 2016

    Vital Signs - Impact of Strategic Acquisitions on Life Sciences Market, 2016

    Portfolio Expansions Follow Acquisitions by Panasonic Healthcare Holdings Co.,Thermo Fisher Scientific and Abbott Laboratories

    Region : Global

    This Vital Signs issues discusses Panasonic Healthcare's completed acquisition of Bayer's Diabetes Care Unit, Thermo Fisher Scientific's acquisition of Affymetrix, several moves in the single cell-genomics market by Bio-Rad, Illumina, Qiagen, and 10x Genomics, and Abbott's acquisition of Alere.
    USD 450
    Read More
  10. Vital Signs - Technology Developments in Medical Imaging Markets, Radiological Society of North America (RSNA) Meeting 2015
    10
    Feb 2016

    Vital Signs - Technology Developments in Medical Imaging Markets, Radiological Society of North America (RSNA) Meeting 2015

    Medical 3D Printing and Medical Imaging Equipment Asset Management Services, Advanced Enterprise Imaging Informatics Seek to Capture Growth Opportunities

    Region : North America

    \ Frost & Sullivan attended the annual meeting of the Radiological society of North America (RSNA). The four themes we have developed in our coverage of the 2015 edition fall under the topic areas of:\ I- Competitive Landscape and New Business Models, looking at new entrants in the capital imaging equipment arena, the recent developments in techn...
    USD 750
    Read More

Sort By

1-10 of 308

Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5